Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2026 · 10-Q
Revenue$286.56M$286.56M−1.0% vs Q1 2025 Net Income$38.19M$38.19M+13.6% vs Q1 2025 EPS Diluted$0.24$0.24+14.3% vs Q1 2025 Gross Profit$188,112,000+2.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$27,585,000−56.8% Free Cash Flowderived$22,222,000−59.4% Margins · derivedGross margin65.6%+2.4 pt vs Q1 2025
Operating margin16.6%+2.8 pt vs Q1 2025
Net margin13.3%+1.7 pt vs Q1 2025
ended Sep 30, 2025 · filed Nov 5, 2025 · 36 d after period end